Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19)

Fig. 1

MS/MS datasets used in the determination of optimal SARS-CoV-2 peptides for COVID-19 diagnosis. a Cell culture, clinical, and bioinformatic datasets used to generate the SARS-CoV-2 peptide panel. b Clinical datasets queried using the initially characterized peptide panel from (a) to determine the feasibility of COVID-19 diagnosis via targeted proteomics as well as determine the optimal peptide targets for those assays. Figures were made using BioRender

Back to article page

Clinical Proteomics

ISSN: 1559-0275